Black Rock Inc. Eloxx Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.15 - $7.2 $215 - $10,332	-1,435 Reduced 0.4%	357,243 $61,000
Q2 2022 Aug 12, 2022	SELL	$0.24 - $0.58 $34,297 - $82,884	-142,905 Reduced 28.49%	358,678 $97,000
Q1 2022 May 12, 2022	SELL	$0.4 - $0.72 $2,620 - $4,717	-6,552 Reduced 1.29%	501,583 $280,000
Q4 2021 Feb 10, 2022	BUY	$0.62 - $1.61 $10,703 - $27,795	17,264 Added 3.52%	508,135 $360,000
Q3 2021 Nov 09, 2021	BUY	$1.22 - $2.0 $366,186 - $600,306	300,153 Added 157.38%	490,871 $800,000
Q2 2021 Aug 11, 2021	BUY	$1.35 - $3.36 $257,469 - $640,812	190,718 New	190,718 $380,000

Ticker ELOX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,656,200
Description
Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.